Financials
Financial year 2024
NEOGEN from Anderlecht, company number BE0445922856, closed financial year 2024 with a result of € 3 million after tax. For that financial year NEOGEN recorded a gross margin of € 2.8 million and equity of € 11.7 million. Compared with financial year 2023, the result moved from € 2.9 million to € 3 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 25, 2025.
€ 11.7 million
▲ 35% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 3 million
▲ 6% vs 2023
Profit after tax over the fiscal year.
€ 48,607
▼ 25% vs 2023
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2024. Retained profit grew to € -709,588.
Debts at end 2024
None
No bank loans on the last day of the fiscal year.
€ 331,329
▼ 60% vs 2023
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 1,607,335 | € 1,801,418 | € 2,798,557 | € 2,779,710 | ▼ 1% |
| Profit after taxes | € 76,058 | € 939,744 | € 2,851,128 | € 3,018,440 | ▲ 6% |
| Equity | € 4,873,700 | € 5,813,444 | € 8,664,572 | € 11,683,012 | ▲ 35% |
| Total debts | € 6,134,904 | € 5,288,489 | € 4,436,921 | € 3,511,082 | ▼ 21% |
| Cash | € 56,814 | € 103,875 | € 64,484 | € 48,607 | ▼ 25% |
| Retained profit | € -7,518,900 | € -6,579,156 | € -3,728,028 | € -709,588 | ▲ € 3 million |
| Balance sheet total | € 11,008,604 | € 11,101,933 | € 13,101,493 | € 15,194,094 | ▲ 16% |
Key figures of NEOGEN, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to NEOGEN?
What happened at NEOGEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 3 million (▲ 6% vs 2023). filed late Source: NBB ↗
- Cellular Consulting stepped down as director. NBB
- LMDC GmbH stepped down as director. NBB
- HFS BV stepped down as director. NBB
- LMDC GmbH became a director. NBB
- Cellular Consulting became a director. NBB
- HFS BV became a director. NBB
- New establishment in Anderlecht. KBO
In short
From € 76,058 profit in 2021 to € 3 million profit in 2024.
Best year ever: 2024, with € 3 million profit.
A new publication or filing at NEOGEN? We notify you, reason included.
Follow NEOGENDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of A.forall Development comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
NEOGENThe shares are held by A.forall Development (100%).
Directors
According to the 2024 annual accounts
Director · represented by Bruno Febra
since 2022 · until 2025
Director · represented by Ivo Peeters
Also active at: ECOPHARMASUPPLY DISTRIBUTION, IMPEXECO, ECO.PHARMA.SUPPLY, MEDIGROUP, A.forall Development, PI PHARMA
since 2020 · until 2024
since 2024 · until 2025
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Marie Curiesquare 50
1070 Anderlecht
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0445.922.856
- VAT number
- BE 0445.922.856
- Registered office
- Marie Curiesquare 50, 1070 Anderlecht
- Names & denominations
- NEOGEN
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 9 December 1991
- Peppol
- Active · Active since 6 Jan 2026
- Activities · NACE
Vervaardiging van geneesmiddelen